2018 was a ground-breaking year for orphan disease with the FDA approving a record 34 new therapies for rare populations. Clearly, the steps laid out
Pharma marketers experienced both flops and wins in 2018 – here’s how to apply these learnings to drive impact in the new year.
Leverage paid search, social, and programmatic to take home the prize
The bad news is healthcare providers have never been more difficult for sales forces to reach. The good news is that HCPs are increasingly embracing
Guide evolved pharma portfolio management and planning with these principles